A bioequivalent prodrug of the DNA topoisomerase II inhibitor Etoposide. Antineoplastic used in the treatment of a wide variety of hematological malignancies and solid tumors.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.